Looking for a job

Kellie Terry

@kellieterry

Enterprise transformation executive at Regeneron redesigning workflows with AI-enabled solutions and building governance for its Digital Data Flow transformation.

United States

Message

At Regeneron Pharmaceuticals, I’m leading the enterprise Digital Data Flow transformation across Digital Protocol, STARS, and AI-enabled capabilities. I’m building its operating model and governance from the ground up while redesigning workflows to embed AI-driven, outcome-focused solutions.

I built a quantified enterprise value case targeting a 30% throughput increase and approximately $150M in annual savings or avoidance. Governance standardization and operating model redesign reduced cycle times by more than 30% and increased portfolio delivery throughput by 25%.

At Johnson & Johnson, I established enterprise governance models and managed platform and finance transformation portfolios. For a $1B+ global finance transformation, I owned the investment case and governance against a $197M annual savings target; the PMO approach improved on-time delivery by 25% and reduced program delays by 40%.

My work has also included managing Janssen R&D’s $2B annual oncology portfolio, leading a $2B business transformation at inVentiv Health (now Syneos Health), and driving commercial IT portfolio initiatives at AstraZeneca. I’m a PMP and hold a Bachelor of Science in Business Administration.

Experience

Work history, roles, and key accomplishments

Current

Senior Director, Transformation Program Management

Current

Regeneron Pharmaceuticals

Jan 2025 - Present (1 year 10 months)

Owns end-to-end delivery of enterprise Digital Data Flow transformation, building operating model and governance from ground up. Leads redesign of workflows embedding AI solutions, targeting 30% throughput increase and ~$150M annual savings.

AI Operating Model Design Governance Program Management Executive Reporting Dashboarding Change Management

Senior Director, Inclusion & Strategy Program Management

Johnson & Johnson

Jan 2022 - Dec 2024 (2 years 11 months)

Stood up enterprise governance model, establishing strategy frameworks and OKR alignment. Drove 80% increase in leadership engagement and 25% improvement in retention through workforce-focused programs.

OKRs Governance Executive Communication Data Dashboards Change Management

Director, Enterprise PMO

Johnson & Johnson

Jan 2020 - Dec 2022 (2 years 11 months)

Owned investment case and governance for $1B+ global finance transformation with $197M annual savings target. Built enterprise PMO governance, improving on-time delivery 25% and reducing program delays 40%.

PMO Governance RAID Benefits Tracking Executive Reporting Red Team

Associate Director, Clinical Functional Planning

Janssen R&D (Johnson & Johnson)

Jan 2016 - Dec 2020 (4 years 11 months)

Managed $2B annual oncology portfolio, coordinating cross-functional planning across Clinical, Regulatory, and Finance. Reduced budget overruns 25% and improved program completion rates 30%.

Portfolio Management Budgetary Governance Process Optimization Cross functional Coordination

Senior Director, Business Transformation Management Office

inVentiv Health (now Syneos Health)

Jan 2013 - Dec 2016 (3 years 11 months)

Led business transformation strategy for $2B business across US and Canada, directing $30M budget and leading team of 25. Reduced IT costs 4.1% and increased employee engagement from 56% to 73%.

Strategy And Transformation Budget Management Governance Employee Engagement

Senior Portfolio Manager, North America Commercial IT PMO

AstraZeneca

Jan 2010 - Dec 2013 (3 years 11 months)

Led strategic initiatives across global commercial portfolio, improving time-to-market 20-30% and driving 40% increase in customer engagement through digital transformation programs.

Portfolio Management Digital Transformation Time To Market Customer Engagement